SEC Form 4 · accession 0001144204-15-051370

Harvard Apparatus Regenerative Technology, Inc. · HRGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Aug 19, 2015

Accepted (ET)

Aug 21, 2015 · 5:17 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001563665

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Aug 19, 2015	P	75,000	$0.62	A	131,128	D
Common Stock^F3,F4	Aug 21, 2015	P	25,000	$0.76	A	156,128	D

No Table II lines on this filing.

F1This transaction was executed in multiple trades at prices ranging from $0.59 to $0.66. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 130,023 shares of common stock held by the Reporting Person.
F3This transaction was executed in multiple trades at prices ranging from $0.72 to $0.78. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 155,023 shares of common stock held by the Reporting Person.

Exhibit List: Exhibit 24 - Limited Power of Attorney